We came across a bullish thesis on Harrow, Inc. on MVC Investing’s Substack by M. V. Cunha. In this article, we will summarize the bulls’ thesis on HROW. Harrow, Inc.’s share was trading at $47.69 as of February 16th. HROW’s trailing and forward P/E were 9.64 and 44.25 respectively according to Yahoo Finance.
Tyler Olson/Shutterstock.com
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical...
